Darren Pan, MD
Education
Publications
Avigan ZM, Bodnar S, Pan D, Catlett J, Richter J, Sanchez LJ, Rodriguez C, Rossi AC, Richard S, Jagannath S, Cho HJ, Parekh S, Thibaud S. Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival. Volume 9 of Issue 1. Blood advances 2025. PMID: 39383457
Avigan ZM, Arinsburg S, Pan D, Mark T, Fausel C, Bubalo J, Milkovich G, Moshier E, Fu W, Chari A, Richter J. Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma. Bone marrow transplantation 2024. PMID: 39424960
Pan D, Richter J. Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma. Volume 19 of Issue 6. Current hematologic malignancy reports 2024. PMID: 39145912
Mejia Saldarriaga M, Pan D, Unkenholz C, Mouhieddine TH, Velez-Hernandez JE, Engles K, Fein JA, Monge J, Rosenbaum C, Pearse R, Jayabalan D, Gordillo C, Chan HT, Yamshon S, Thibaud S, Mapara M, Inghirami G, Lentzsch S, Reshef R, Rossi A, Parekh S, Jagannath S, Richard S, Niesvizky R, Bustoros M. Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Volume 8 of Issue 15. Blood advances 2024. PMID: 38776397
Avigan ZM, Arinsburg S, Pan D, Mark T, Fausel C, Bubalo J, Milkovich G, Chari A, Richter J. Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma. Bone marrow transplantation 2024. PMID: 39085373
Richter J, Pan D, Salinardi T, Rice MS. Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States. Volume 4 of Issue 4. EJHaem 2023. PMID: 38024614
Pan D, Richter J. Teclistamab for Multiple Myeloma: Clinical Insights and Practical Considerations for a First-in-Class Bispecific Antibody. Volume 15. Cancer management and research 2023. PMID: 37497430
Mouhieddine TH, Van Oekelen O, Melnekoff DT, Li J, Ghodke-Puranik Y, Lancman G, Thibaud S, Pan D, Rajeeve S, Agte S, Aleman A, Sanchez L, Richard S, Rossi A, Richter J, Cho HJ, Rodriguez C, Lagana A, Moshier E, Chari A, Jagannath S, Parekh S. Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma. Blood advances 2023. PMID: 36018226
Pan D, Mouhieddine TH, Upadhyay R, Casasanta N, Lee A, Zubizarreta N, Moshier E, Richter J. Outcomes with panobinostat in heavily pretreated multiple myeloma patients. Volume 50 of Issue 1-2. Seminars in oncology 2023. PMID: 37005144
Pan D, Richter J. Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams. Volume 11. Frontiers in oncology 2022. PMID: 35127532
Pan D, Kaufman JL, Htut M, Agrawal M, Mazumder A, Cornell RF, Zonder JA, Fay JW, Modiano MR, Moshier EL, Rush SA, Tunquist BJ, Chari A. Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma. Cancer medicine 2021. PMID: 34921527
Pan D, Ip A, Zhan S, Wasserman I, Snyder DJ, Agathis AZ, Shamapant N, Yang JY, Pai A, Mazumdar M, Poor H. Pre-hospital antiplatelet medication use on COVID-19 disease severity. Volume 50 of Issue 5. Heart & lung : the journal of critical care 2021. PMID: 34090177
Pan D, Coltoff A, Ozbek U, Lin JY, Afshar S, Galitzeck Z, Steinberg A. Evaluating Race and Time to Transplantation in Multiple Myeloma: The Mount Sinai Hospital Experience. Volume 21 of Issue 7. Clinical lymphoma, myeloma & leukemia 2021. PMID: 33757769
Pan D, Rampal R, Mascarenhas J. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia. Volume 4 of Issue 5. Blood advances 2020. PMID: 32150613
Molina A, Winston DJ, Pan D, Schiller GJ. Response. Volume 24 of Issue 9. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018. PMID: 29909155
Molina A, Winston DJ, Pan D, Schiller GJ. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Volume 24 of Issue 8. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018. PMID: 29555315